Ihor Boszko

Ihor Boszko joined SickKids as the Executive Director of the Industry Partnerships & Commercialization team in November 2018, bringing close to two decades of experience in the life sciences sector. Previously, Ihor spent fifteen years in the in vitro diagnostics industry developing, commercializing and partnering innovative molecular diagnostic technologies at Tm Bioscience (TSXV: TMC), Luminex (NASDAQ: LMNX) and venture-backed start-up Xagenic. He also worked at DRI Capital and Ontario Genomics. Ihor holds an M.Sc. from McMaster University, an MBA from Queen’s University and completed the Corporate Governance program at the Kellogg School of Management (Northwestern University). He is currently a Board Observer of Radiant Biotherapeutics.

Relevant pages